A Phase I Open-Label Dose-Escalation Study of Intravenous BI 2536 Together With Pemetrexed in Previously Treated Patients With Non–Small-Cell Lung Cancer

Authors:
  • QCQuincy S. Chu
    Quincy S. Chu
  • NLNatasha Leighl
    Natasha Leighl
  • SLScott A. Laurie
    Scott A. Laurie
  • HFHolger Fritsch
    Holger Fritsch
  • BGBirgit Gaschler-Markefski
    Birgit Gaschler-Markefski
  • SGSteve Gyorffy
    Steve Gyorffy
  • GMGerd Munzert
    Gerd Munzert

Abstract
No abstract available

This publication has 25 references indexed in Scilit: